Filed: 2/17/2026ACC: 0001964437-26-000003
📋 What this filing means
SATURN V CAPITAL MANAGEMENT LP filed this quarterly 13F‑HR report disclosing 20 equity positions with a total reported market value of $544.90M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
20
Positions
$544.90M
Total AUM (reported)
39.89M
Total Shares
Allocation by class
COM$344.10M63.1%
SPONSORED ADS$94.62M17.4%
COM NEW$52.38M9.6%
SHS USD$42.17M7.7%
ORDINARY SHARES$10.32M1.9%
ADS$1.32M0.2%
Portfolio Concentration
Top 3$185.09M34.0%
4–10$231.59M42.5%
11–25$128.22M23.5%
Top 3 weight
34.0%
Top 10 weight
76.5%
Voting Authority Distribution
Total shares with voting rights: 39.89M
Sole
Full voting authority
39.89M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole20
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings20
Rows:
ABIVAX SA
SOLEShares649.18K
TypeSH
Market value$87.55M
16.07%
Sole
649.18K
Shared
0.00
None
0.00
AMYLYX PHARMACEUTICALS INC
SOLEShares4.50M
TypeSH
Market value$54.32M
9.97%
Sole
4.50M
Shared
0.00
None
0.00
COGENT BIOSCIENCES INC
SOLEShares1.22M
TypeSH
Market value$43.23M
7.93%
Sole
1.22M
Shared
0.00
None
0.00
JAZZ PHARMACEUTICALS PLC
SOLEShares248.07K
TypeSH
Market value$42.17M
7.74%
Sole
248.07K
Shared
0.00
None
0.00
VAXCYTE INC
SOLEShares798.94K
TypeSH
Market value$36.86M
6.77%
Sole
798.94K
Shared
0.00
None
0.00
DYNE THERAPEUTICS INC
SOLEShares1.79M
TypeSH
Market value$34.99M
6.42%
Sole
1.79M
Shared
0.00
None
0.00
PHARVARIS N V
SOLEShares1.14M
TypeSH
Market value$31.64M
5.81%
Sole
1.14M
Shared
0.00
None
0.00
CELCUITY INC
SOLEShares317.10K
TypeSH
Market value$31.63M
5.80%
Sole
317.10K
Shared
0.00
None
0.00
ALUMIS INC
SOLEShares3.14M
TypeSH
Market value$30.61M
5.62%
Sole
3.14M
Shared
0.00
None
0.00
DISC MEDICINE INC
SOLEShares298.43K
TypeSH
Market value$23.70M
4.35%
Sole
298.43K
Shared
0.00
None
0.00
X4 PHARMACEUTICALS INC
SOLEShares5.80M
TypeSH
Market value$23.20M
4.26%
Sole
5.80M
Shared
0.00
None
0.00
MONOPAR THERAPEUTICS INC
SOLEShares325.70K
TypeSH
Market value$21.27M
3.90%
Sole
325.70K
Shared
0.00
None
0.00
INVIVYD INC
SOLEShares7.74M
TypeSH
Market value$19.11M
3.51%
Sole
7.74M
Shared
0.00
None
0.00
OCULAR THERAPEUTIX INC
SOLEShares1.50M
TypeSH
Market value$18.27M
3.35%
Sole
1.50M
Shared
0.00
None
0.00
IMMIX BIOPHARMA INC
SOLEShares3M
TypeSH
Market value$15.69M
2.88%
Sole
3M
Shared
0.00
None
0.00
OCULIS HOLDING AG
SOLEShares516.76K
TypeSH
Market value$10.32M
1.89%
Sole
516.76K
Shared
0.00
None
0.00
INHIBIKASE THERAPEUTICS INC
SOLEShares3.86M
TypeSH
Market value$7.91M
1.45%
Sole
3.86M
Shared
0.00
None
0.00
CENTESSA PHARMACEUTICALS PLC
SOLEShares282.69K
TypeSH
Market value$7.07M
1.30%
Sole
282.69K
Shared
0.00
None
0.00
OVID THERAPEUTICS INC
SOLEShares2.50M
TypeSH
Market value$4.08M
0.75%
Sole
2.50M
Shared
0.00
None
0.00
INVENTIVA SA
SOLEShares283.17K
TypeSH
Market value$1.32M
0.24%
Sole
283.17K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
ABIVAX SASOLE | SPONSORED ADS | 649.18K | SH | $87.55M 16.07% | 649.18K | 0.00 | 0.00 |
AMYLYX PHARMACEUTICALS INCSOLE | COM | 4.50M | SH | $54.32M 9.97% | 4.50M | 0.00 | 0.00 |
COGENT BIOSCIENCES INCSOLE | COM | 1.22M | SH | $43.23M 7.93% | 1.22M | 0.00 | 0.00 |
JAZZ PHARMACEUTICALS PLCSOLE | SHS USD | 248.07K | SH | $42.17M 7.74% | 248.07K | 0.00 | 0.00 |
VAXCYTE INCSOLE | COM | 798.94K | SH | $36.86M 6.77% | 798.94K | 0.00 | 0.00 |
DYNE THERAPEUTICS INCSOLE | COM | 1.79M | SH | $34.99M 6.42% | 1.79M | 0.00 | 0.00 |
PHARVARIS N VSOLE | COM | 1.14M | SH | $31.64M 5.81% | 1.14M | 0.00 | 0.00 |
CELCUITY INCSOLE | COM | 317.10K | SH | $31.63M 5.80% | 317.10K | 0.00 | 0.00 |
ALUMIS INCSOLE | COM | 3.14M | SH | $30.61M 5.62% | 3.14M | 0.00 | 0.00 |
DISC MEDICINE INCSOLE | COM | 298.43K | SH | $23.70M 4.35% | 298.43K | 0.00 | 0.00 |
X4 PHARMACEUTICALS INCSOLE | COM NEW | 5.80M | SH | $23.20M 4.26% | 5.80M | 0.00 | 0.00 |
MONOPAR THERAPEUTICS INCSOLE | COM NEW | 325.70K | SH | $21.27M 3.90% | 325.70K | 0.00 | 0.00 |
INVIVYD INCSOLE | COM | 7.74M | SH | $19.11M 3.51% | 7.74M | 0.00 | 0.00 |
OCULAR THERAPEUTIX INCSOLE | COM | 1.50M | SH | $18.27M 3.35% | 1.50M | 0.00 | 0.00 |
IMMIX BIOPHARMA INCSOLE | COM | 3M | SH | $15.69M 2.88% | 3M | 0.00 | 0.00 |
OCULIS HOLDING AGSOLE | ORDINARY SHARES | 516.76K | SH | $10.32M 1.89% | 516.76K | 0.00 | 0.00 |
INHIBIKASE THERAPEUTICS INCSOLE | COM NEW | 3.86M | SH | $7.91M 1.45% | 3.86M | 0.00 | 0.00 |
CENTESSA PHARMACEUTICALS PLCSOLE | SPONSORED ADS | 282.69K | SH | $7.07M 1.30% | 282.69K | 0.00 | 0.00 |
OVID THERAPEUTICS INCSOLE | COM | 2.50M | SH | $4.08M 0.75% | 2.50M | 0.00 | 0.00 |
INVENTIVA SASOLE | ADS | 283.17K | SH | $1.32M 0.24% | 283.17K | 0.00 | 0.00 |